Trillium Therapeutics Inc.
Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins

Last updated:

Abstract:

A novel class of fluorinated derivatives of Formula I have been prepared and found to be useful in the treatment of cancers and other disorders related mediated by Bromodomain-Containing Proteins. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

11 Mar 2019

Issue date:

30 Jun 2020